The Problem
Cancer is usually detected in late stages
A vast majority of cancers show no symptoms until late stages, when treatment is complex, painful, traumatic, with poor clinical outcomes and high medical costs.
^ Diagnostic and treatment cost are estimates based on mapping of private hospital costs with cancer diagnostic & treatment pathways per stage of detection
India’s cancer reality
1 in 10 Indians will develop cancer during their lifetime
*Source: https://www.hindustantimes.com/india-news/one-in-10-indians-will-develop-cancer-during-their-lifetime-who/story-NcNQhPTS01YWI9Qovfcy5J.html
1 in 9 Indians will develop cancer during their lifetime
*Source: https://www.hindustantimes.com/lifestyle/health/cancer-risk-factors-here-s-why-indians-are-at-a-higher-risk-of-the-disease-101675603191553.html
Cancer is a global killer caused by the silent growth & invasion of malignant tumors across different organs of an individual’s body.
In selected countries, regular screening examinations exist for only 6 (3%) out of more than 200 types of cancer known globally.
A large majority of the 1.3 million (per Globocan 2020) new cancer cases each year show up in late-stages (3,4) of cancer.
This huge cancer screening gap leads to late-stage detection which is associated with high death rate and high medical costs for payors of cancer treatment costs.
The Solution
Introducing game changing cancer screening blood test
PanTum Detect screens healthy adults for dangerous tumors covering all solid cancers
Give life a chance
Introducing Cancer-Scan Program Initiated by pre-testing with PanTum Detect
Combines pre-testing and targeted follow-up cancer diagnostics only for those screened candidates that test positive with PanTum Detect blood test.
Innovative & Unique
The EDIM technology is backed by science and more than 20 years of research
Leveraging the immune system to deliver high accuracy of PanTum® Detect test
The human immune system is first to recognize the progression of disease, even before the onset of symptoms. EDIM® (Epitope Detection in Monocytes/Macrophages) technology makes the information contained in the human immune system visible for detection of cancer. Higher than normal levels of Apo10 (DNaseX) & TKTL1 detected in immune cells (macrophages) of screened individuals gives an indication of potential cancer and pre-cancer lesions in early and symptomless stages for healthy individuals.
Leveraging the immune system to deliver high accuracy of PanTum® Detect test
The human immune system is first to recognize the progression of disease, even before the onset of symptoms. EDIM® (Epitope Detection in Monocytes/Macrophages) technology makes the information contained in the human immune system visible for detection of cancer. Higher than normal levels of Apo10 (DNaseX) & TKTL1 detected in immune cells (macrophages) of screened individuals gives an indication of potential cancer and pre-cancer lesions in early and symptomless stages for healthy individuals.
Connect with us for any queries
Connect with us for any queries
Useful Links
Support
Locate Us
© 2023. All rights reserved